SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-049292
Filing Date
2012-02-09
Accepted
2012-02-09 16:16:31
Documents
9
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d282387d10q.htm 10-Q 308110
2 SECTION 302 CEO CERTIFICATION d282387dex311.htm EX-31.1 8423
3 SECTION 302 CFO CERTIFICATION d282387dex312.htm EX-31.2 8414
4 SECTION 906 CEO AND CFO CERTIFICATION d282387dex321.htm EX-32.1 5698
  Complete submission text file 0001193125-12-049292.txt   1382278

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT myrx-20111231.xml EX-101.INS 153822
6 XBRL TAXONOMY EXTENSION SCHEMA myrx-20111231.xsd EX-101.SCH 8555
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE myrx-20111231_cal.xml EX-101.CAL 24785
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE myrx-20111231_lab.xml EX-101.LAB 91534
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myrx-20111231_pre.xml EX-101.PRE 56911
Mailing Address 305 CHIPETA WAY SALT LAKE CITY UT 84108
Business Address 305 CHIPETA WAY SALT LAKE CITY UT 84108 801-214-7800
Myrexis, Inc. (Filer) CIK: 0001459450 (see all company filings)

IRS No.: 263996918 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-34275 | Film No.: 12587407
SIC: 2834 Pharmaceutical Preparations